Rheumatic Disease Center

How to Manage Arthritis Pain
Are you one of the millions in the United States with arthritis?
Why Does Winter Worsen Arthritis Symptoms?
If you feel your arthritis symptoms getting worse when winter comes, you are not alone. But what causes this issue?
A New Rx for a Rare Disease
The US Food and Drug Administration (FDA) has approved a new medication for a rare disease.
Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.
Cryotherapy a Cool Trend After All?
Whole-body cryotherapy may not be so cool after all, according to the US Food and Drug Administration (FDA).
Possible RA?
Find A Prescription Treatment For Moderate or Severe RA
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Learn About an FDA Approved Treatment for Rheumatoid Arthritis
New Treatment for Rare Genetic Condition
The US Food and Drug Administration (FDA) has approved a new treatment for a rare genetic disease.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
That Anti-Inflammatory Rx May Have an Extra Benefit
Medications used to treat conditions like psoriasis and rheumatoid arthritis may also be able to treat depression symptoms, a new study found.
Three Rare Diseases Get New Treatment Option
The US Food and Drug Administration (FDA) has approved a new treatment option for three rare diseases.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept. 
Are 'Generic' Biologics the Same as the 'Brand'?
Generic versions of often expensive brand-name biologic medications appear safe and effective on the whole, a new study found.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
Novel Arthritis Rx Shows Promise
It's not yet approved by the US Food and Drug Administration (FDA), but a new refractory rheumatoid arthritis drug has shown potential in a phase III trial.
Experimental Lupus Rx Shows Promise
Lupus is a chronic and often disabling disease with very few treatment options. But there may be some hope on the horizon where that is concerned.
Good News for Rheumatoid Arthritis Treatment
Anti-TNFs are a class of medications often used to treat inflammatory conditions like rheumatoid arthritis (RA). But when an anti-TNF fails, what's the next step?
Could Antibiotics Be Tied to Arthritis in Kids?
Antibiotics are miracle drugs that have saved millions of lives, but some worry that their overuse could have serious consequences. Now there may be yet another cause for concern.